Effects of Spirulina Supplementation on Mental Health in Healthy Adults
NCT ID: NCT06936202
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-04-15
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spirulina Supplementation and Cardiovascular Risk in Obese Caucasians With Treated Hypertension
NCT02575690
Effects of Spirulina Supplementation on Overweight or Obese Adults
NCT02993627
Hypolipidemic and Antioxidant Capacity of Spirulina and Exercise
NCT02837666
Spirulina Supplementation In Recovery From Damaging Exercise
NCT06391957
Evaluation of the Effect of Spirulina-Silicon Supplementation on the Morphological, Biomechanical and Functional Characteristics of the Arterial Wall in the Elderly
NCT03464760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is evident that Spirulina supports brain health through neuroprotection, antioxidants, anti-inflammatory properties, and hormone regulation. Research supports Spirulina reversing neurodegenerative diseases due to several of these beneficial properties. There have been many studies that utilize Spirulina to improve cognitive function in Alzheimer's Disease, Parkinson's Disease, ulcerative colitis, IBD, fibromyalgia and even in TBI and Ischemic stroke.
Although many of these diseases have depressive symptoms, few of these studies have evaluated the impact of Spirulina on mood. Furthermore, no studies have been conducted relating depression and the cyanobacteria. It is possible that Spirulina supplements can be used to reduce feelings of hopelessness and lack of energy, by providing additional vitamins, minerals, amino acids, and fatty acids, on a daily basis. This study aims to compare spirulina and its improvement on mood, in health college students, by daily supplementation of 3g of Spirulina over a span of 8 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
spirulina capsules
six capsules daily (totaling 3 g)
Spirulina capsules
active intervention
Placebo
Pea powder - 6 capsules daily
Placebo
no active ingredient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spirulina capsules
active intervention
Placebo
no active ingredient
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ages 18-65
* no underlying chronic disease or acute conditions
* no autoimmune conditions
* do not consume alcohol in excess, smoke, use recreational drugs
* does not follow restrictive diets
* will be recruited from the ASU university campus.
Exclusion Criteria
* not taking antidepressants, anxiety, or stress medications, or any other medications
* drugs, or supplements that could influence mental capacities
* not pregnant or breastfeeding
* not a competitive athlete
16 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carol Johnston
Professor and Senior Associate Dean
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
850 PBC
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00021993
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.